EUDA Health Holdings Limited announced on April 24, 2025, an update to its potential strategic partnership with Guangdong Cell Biotech Co. Ltd., initially discussed in December 2024. EUDA is now partnering with an authorized distributor of Guangdong Cell Biotech.
This partnership enables EUDA to offer stem cell therapies to customers in Singapore and Malaysia. Guangdong Cell Biotech is known for its expertise in stem cell therapies and regenerative medicine, enhancing EUDA's service offerings.
This development represents a step forward in EUDA's strategic pivot into advanced biotechnology, allowing it to introduce innovative treatment options to its target markets. The collaboration aims to enhance EUDA's product offerings and market presence in the region.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.